Home/Chemicals and Materials/Specialty Chemicals/Cannabidiol Market

Cannabidiol Market - Strategic Insights and Forecasts (2026-2031)

Market Size, Share and Forecast By Source (Hemp, Marijuana), By Product Type (Oil, Tablets & Capsules, Gummies, Others), By Sales Type (B2B, B2C), By End-user (Pharmaceuticals, Personal Care & Cosmetics, Food & Beverage, Others), and Geography

Market Size in 2026
USD 10.035 billion
Market Size in 2031
USD 23.693 billion
CAGR
15.39%
Study Period
2021-2031
$3,950
Single User License
Report OverviewSegmentationTable of ContentsCustomize Report

Report Overview

Cannabidiol Market, at a 15.39% CAGR, is projected to increase from USD 10.035 billion in 2025 to USD 23.693 billion in 2031.

Cannabidiol Market - Strategic Insights and Forecasts (2026-2031) market growth projection from $10.04B in 2026 to $23.69B by 2031 at a CAGR of 15.39%.
Cannabidiol Market - Strategic Insights and Forecasts (2026-2031) market growth projection from $10.04B in 2026 to $23.69B by 2031 at a CAGR of 15.39%.

Highlights:

  1. 1
    Increasing funding and research are driving innovation in cannabidiol-based healthcare products.
  2. 2
    Expanding e-commerce platforms are enabling broader access to CBD consumer products.
  3. 3
    Relaxing global regulations are allowing more cannabidiol products to enter legal markets.
  4. 4
    Growing demand from pharmaceutical and wellness sectors is boosting cannabidiol product development.

Hemp is typically used because of its naturally high cannabidiol (CBD) content. While CBD is a crucial component of medicinal marijuana, it is either produced in a lab or is taken straight from the hemp plant, a relative of the marijuana plant. Cannabidiol is the cannabinoid that is most frequently utilized for medicinal purposes due to its absence of psychotropic effects. Cannabidiol oil for instance is utilised in various medical procedures, including the treatment of anxiety and depression, the reduction of stress, the prevention of diabetes, the reduction of pain and inflammation, and the treatment of cancer symptoms.

Cannabidiol Market Growth Drivers:

  • Growth drivers for the cannabidiol market

Increased funding for research and development to better understand cannabidiol's effects and create new products is the result of rising interest in the substance's potential health benefits. The cannabidiol market is anticipated to expand as hemp-based goods become permitted. To satisfy customer demand, businesses are creating a range of cannabidiol products, including candies, topicals, and drinks. Businesses can reach a larger audience and boost sales through online channels due to the growth of e-commerce.

Cannabidiol Market Segmentation Analysis:

  • Increase in patients suffering from chronic illness

In both industrialized and emerging nations, the frequency of chronic illness is increasing, which has increased the incidence of several neurological diseases including Parkinson's and Alzheimer's and this is impacting the cannabidiol market growth. According to a WHO estimate, more than 55 million individuals worldwide had dementia in 2017. Additionally, an Alzheimer's Association analysis estimates that by 2021, dementia would affect nearly 6 million elderly Americans. Additionally, there is a huge surge in people suffering from cancer and diabetes worldwide further propelling the cannabidiol market.

  • Government approvals for CBD products

Government restrictions are stringent, and CBD-based goods needed permits before they could be sold and supplied on the domestic and foreign markets. However, as marijuana and products derived from it have become more and more legal for a variety of uses, regulations have been loosened, and refined CBD products are becoming more and more popular. This is anticipated to fuel the cannabidiol market expansion and demand.

Additionally, there are significant producers of CBD products all over the world, which has led the government and other regulatory bodies, including the European Union in Europe and the United States, to relax their regulations on CBD and CBD-based products.

  • Increasing clinical trials and product utilization in the pharmaceutical industry

The cannabidiol market share is projected to increase over the projected period as a result of the rising number of research trials examining the benefits of CBD on various health issues. Additionally, a lot of businesses buy CBD oil in bulk and create CBD-infused goods that are extensively utilized by customers as an alternative to managing stress and discomfort.

As a result, the cannabidiol market for these items is probably in a growing phase. Over the projection period, the pharmaceutical industry is anticipated to grow at the quickest rate. Cannabidiol's transition from natural treatments to prescription medications is probably what will spur the cannabidiol market growth. The pharmaceutical industry's demand for these products is also anticipated to increase as more people become aware of cannabidiol's medicinal potential.

  • Growing demand in end-user industries

It is anticipated that growing demand for cannabidiol from a variety of end-user sectors, including food and beverage, personal care and cosmetics, and pharmaceuticals, would provide the cannabidiol market tremendous potential prospects. The need for cannabidiol products that are chemically and minimally prepared has also created a lucrative potential to grow the industry. With the commercialization of several products using cannabidiol in the production process, high levels of demand from hospitals are therefore anticipated to propel market expansion.

  • Growing demand for CBD products

The cannabidiol market is anticipated to rise due to the high demand for CBD products including oils, tinctures, concentrates, capsules, topical treatments like salves, lip balms, and lotions, as well as consumables like baked goods, coffee, chocolate, gum, and candies. Furthermore, hemp-derived CBD has a wide range of uses due to its antioxidant properties and capacity to combat aging and inflammation. CBD-infused products are being developed across a range of industries, including medicines, personal care, nutraceuticals, and food and beverage.

Cannabidiol Market Geographical Outlook:

  • The North American cannabidiol market is anticipated to grow significantly.

North American cannabidiol market is propelling due to a variety of reasons, including a sizable population of health-conscious people, increasing consumer acceptance of CBD products, the existence of major producers, and the ratification of the U.S. Farm Bill in 2020. With the most CBD firms and lax rules governing the use of CBD products, the region is regarded as the most advanced in cannabis and related products, including CBD.

  • Increasing investment and product innovation by key players

With an increase in the number of new businesses selling comparable items, the cannabidiol industry is becoming more competitive. Consumers have been compelled to buy these products, even though they are pricey, due to the rising understanding of the medicinal advantages of cannabidiol. Commercial shops are concentrating on marketing cannabis-based products because they offer a bigger profit margin. CBD-based products are now widely available at several health and wellness retailers. It is advertised for its alleged health advantages, which include easing pain and anxiety.

List of Top Cannabidiol Companies:

  • ENDOCA

  • Cannoid, LLC

  • Mayo Clinic

  • Folium Biosciences

  • Elixinol

Cannabidiol Market Scope:

Report Metric Details
Total Market Size in 2026 USD 10.035 billion
Total Market Size in 2031 USD 23.693 billion
Forecast Unit USD Billion
Growth Rate 15.39%
Study Period 2021 to 2031
Historical Data 2021 to 2024
Base Year 2025
Forecast Period 2026 – 2031
Segmentation Source, Product Type, Sales Type, Geography
Geographical Segmentation North America, South America, Europe, Middle East and Africa, Asia Pacific
Companies
  • ENDOCA
  • Cannoid LLC
  • Elixinol Wellness Limited
  • NuLeaf Naturals LLC (High Tide Inc.)
  • Isodiol International Inc.

Market Segmentation

By Source

Hemp
Marijuana

By Product Type

Oil
Tablets & Capsules
Gummies
Others

By Sales Type

B2B
B2C

By End-user

Pharmaceuticals
Personal Care & Cosmetics
Food & Beverage
Others

By Geography

North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
Germany
France
United Kingdom
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Israel
Others
Asia Pacific
China
India
Japan
South Korea
Indonesia
Thailand
Others

Table of Contents

1. EXECUTIVE SUMMARY 

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE 

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities 

3.4. Porter’s Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations 

3.7. Strategic Recommendations 

4. TECHNOLOGICAL OUTLOOK

5. CANNABIDIOL MARKET BY SOURCE

5.1. Introduction

5.2. Hemp

5.3. Marijuana

6. CANNABIDIOL MARKET BY PRODUCT TYPE

6.1. Introduction

6.2. Oil

6.3. Tablets & Capsules

6.4. Gummies

6.5. Others

7. CANNABIDIOL MARKET BY SALES TYPE

7.1. Introduction

7.2. B2B

7.3. B2C

8. CANNABIDIOL MARKET BY END-USER

8.1. Introduction

8.2. Pharmaceuticals

8.3. Personal Care & Cosmetics

8.4. Food & Beverage

8.5. Others

9. CANNABIDIOL MARKET BY GEOGRAPHY

9.1. Introduction

9.2. North America

9.2.1. USA

9.2.2. Canada

9.2.3. Mexico

9.3. South America

9.3.1. Brazil

9.3.2. Argentina

9.3.3. Others

9.4. Europe

9.4.1. Germany

9.4.2. France

9.4.3. United Kingdom

9.4.4. Spain

9.4.5. Others

9.5. Middle East and Africa

9.5.1. Saudi Arabia

9.5.2. UAE

9.5.3. Israel

9.5.4. Others

9.6. Asia Pacific

9.6.1. China

9.6.2. India

9.6.3. Japan

9.6.4. South Korea

9.6.5. Indonesia

9.6.6. Thailand

9.6.7. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

10.1. Major Players and Strategy Analysis

10.2. Market Share Analysis

10.3. Mergers, Acquisitions, Agreements, and Collaborations

10.4. Competitive Dashboard

11. COMPANY PROFILES

11.1. ENDOCA

11.2. Cannoid, LLC

11.3. Elixinol Wellness Limited

11.4. NuLeaf Naturals, LLC (High Tide Inc.)

11.5. Isodiol International, Inc.

11.6. Pharmahemp d.o.o.

11.7. Aurora Cannabis Inc.

11.8. Canopy Growth Corporation

11.9. CV Sciences, Inc

11.10. Medical Marijuana Inc

12. APPENDIX

12.1. Currency 

12.2. Assumptions

12.3. Base and Forecast Years Timeline

12.4. Key benefits for the stakeholders

12.5. Research Methodology 

12.6. Abbreviations 

LIST OF FIGURES

LIST OF TABLES

Need Assistance?

Our research team is available to answer your questions.

Contact Us
Report IDKSI061615891
PublishedJan 2026
Pages140
FormatPDF, Excel, PPT, Dashboard
Frequently Asked Questions

The report forecasts a robust expansion for the Cannabidiol Market, projecting a compound annual growth rate (CAGR) of 15.39%. This growth is expected to increase the market value significantly from USD 10.035 billion in 2025 to an estimated USD 23.693 billion by 2031.

Key growth drivers include increasing funding for research and development to understand cannabidiol's health benefits and create new products. Additionally, the expansion of e-commerce platforms for broader product access, relaxing global regulations, and growing demand from pharmaceutical and wellness sectors are significant factors propelling market expansion.

The report highlights that the increasing prevalence of chronic illnesses, such as neurological diseases like Parkinson's and Alzheimer's, as well as cancer and diabetes, is a major driver for the cannabidiol market. CBD oil is utilized in various medical procedures, including the treatment of anxiety, pain, and inflammation, positioning it as a key component in managing these conditions.

Government regulations and approvals are critical to market expansion. The report indicates that the loosening of stringent restrictions and the increasing legality of marijuana and derived products are anticipated to fuel significant growth. This regulatory shift allows more refined CBD products to enter legal domestic and foreign markets, boosting demand and sales.

While specific regional breakdowns are not detailed in the provided content, the report emphasizes the impact of 'relaxing global regulations' and the increasing incidence of chronic illness in both 'industrialized and emerging nations.' This suggests a broad, global market scope with growth potential influenced by evolving legal frameworks and health demands across various geographies.

The provided content mentions 'significant producers of CBD products all over the' market, implying a dynamic and competitive landscape. While specific company names are not detailed, the report suggests businesses are actively creating a range of cannabidiol products, including candies, topicals, and drinks, to satisfy customer demand and leverage online channels for broader reach.

Need data specifically for your business?Request Custom Research β†’

Trusted by the world's leading organizations

Weber Shandwick
veolia
Tri
tls
TeamViewer
GE Healthcare
Intel
Proctor and Gamble
ABB
Elkem
Defense Logistics Agency
Amazon